Funding for this research was provided by:
UAB Center for AIDS Research ((P30-AI27767) (1R24AI067039-1))
NIH Fogarty Global Health Equity Scholar (TW010540)
Received: 5 April 2019
Accepted: 30 September 2019
First Online: 29 October 2019
Ethics approval and consent to participate
: This study was reviewed and approved by the University of Alabama at Birmingham human subjects institutional review board. Informed consent was waived by the University of Alabama at Birmingham institutional review board due the retrospective nature of the study utilizing a de-identified dataset for analyses.
: Not applicable.
: Greer A. Burkholder has received research support from Bristol-Myers Squibb and Amgen, Inc. and has served as a consultant for Definicare, LLC and Medscape. James H. Willig has received research support from the Bristol-Myers Squibb, Pfizer, Tibotec Therapeutics, and Definicare, LLC, and has consulted for Bristol-Myers Squibb and Gilead Sciences. Andrew O. Westfall has consulted for Definicare, LLC. Cosmas M. Zyambo, Karen L. Cropsey, Craig M. Wilson, C. Ann. Gakumo and Peter S. Hendricks have no competing interests.